메뉴 건너뛰기




Volumn 91, Issue 5, 2018, Pages 996-1006

An overview on Vadimezan (DMXAA): The vascular disrupting agent

Author keywords

ASA404; cancer combination therapy; DMXAA; Vadimezan; vascular disrupting agents (VDAs)

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; SEROTONIN; TUMOR NECROSIS FACTOR; VADIMEZAN; ANTINEOPLASTIC AGENT; CYTOKINE; XANTHONE DERIVATIVE;

EID: 85040860917     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/cbdd.13166     Document Type: Review
Times cited : (89)

References (78)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.